Melissa Kool1, Joost R M van der Sijp2, Judith R Kroep3, Gerrit-Jan Liefers4, Ilse Jannink5, Onno R Guicherit6, Robbert Vree7, Esther Bastiaannet4, Cornelis J H van de Velde4, Perla J Marang-van de Mheen8. 1. Department of Medical Decision Making, Leiden University Medical Center, Leiden, The Netherlands; Department of Surgery, Leiden University Medical Center, Leiden, The Netherlands. 2. Department of Surgery, Medical Center Haaglanden, The Hague, The Netherlands. 3. Department of Clinical Oncology, Leiden University Medical Center, Leiden, The Netherlands. 4. Department of Surgery, Leiden University Medical Center, Leiden, The Netherlands. 5. Department of Surgery, Haga Hospital, The Hague, The Netherlands. 6. Department of Surgery, Bronovo Hospital, The Hague, The Netherlands. 7. Department of Surgery, Diaconessenhuis, Leiden, The Netherlands. 8. Department of Medical Decision Making, Leiden University Medical Center, Leiden, The Netherlands. Electronic address: p.j.marang@lumc.nl.
Abstract
INTRODUCTION: Given increasing numbers of breast cancer survivors, there is an increased focus on quality of life and quality of care. This study aims to investigate whether clinical or patient reported outcomes are most important for perceived quality of care by breast cancer patients. METHODS: Overall, 606 patients aged 18 years or older, who underwent breast cancer surgery 9-18 months ago in five hospitals in the Netherlands, were invited to complete an internet-based questionnaire. Patients were asked to judge a random selection of 24 patient profiles and choose which of 2 presented patients had received the best quality of care, using conjoint analysis. The individual relative importance (RI) for each outcome was estimated using Hierarchical Bayes Estimation, and averaged over all patients to assess which outcomes were most important. RESULTS: Complete data were available for 350 patients (58%). Avoiding severe breast symptoms was most important for good quality of care according to patients (RI 23.22 [95% Confidence Interval (95% CI) 22.32-24.12]), followed by a 2 year longer disease free survival (18.30 [17.38-19.22]). However, the importance differed by age: younger patients (<50 years) assigned higher importance to longer disease free survival (21.99 [19.52-24.46]) than older patients (65 + years) (15.03 [13.88-16.18]). CONCLUSION: Avoiding severe breast symptoms rather than 2 year longer disease free survival is considered most important in our population of breast cancer patients for evaluation of quality of care. These data should thus be included in both information provision prior to treatment choices and post treatment quality of care evaluation.
INTRODUCTION: Given increasing numbers of breast cancer survivors, there is an increased focus on quality of life and quality of care. This study aims to investigate whether clinical or patient reported outcomes are most important for perceived quality of care by breast cancerpatients. METHODS: Overall, 606 patients aged 18 years or older, who underwent breast cancer surgery 9-18 months ago in five hospitals in the Netherlands, were invited to complete an internet-based questionnaire. Patients were asked to judge a random selection of 24 patient profiles and choose which of 2 presented patients had received the best quality of care, using conjoint analysis. The individual relative importance (RI) for each outcome was estimated using Hierarchical Bayes Estimation, and averaged over all patients to assess which outcomes were most important. RESULTS: Complete data were available for 350 patients (58%). Avoiding severe breast symptoms was most important for good quality of care according to patients (RI 23.22 [95% Confidence Interval (95% CI) 22.32-24.12]), followed by a 2 year longer disease free survival (18.30 [17.38-19.22]). However, the importance differed by age: younger patients (<50 years) assigned higher importance to longer disease free survival (21.99 [19.52-24.46]) than older patients (65 + years) (15.03 [13.88-16.18]). CONCLUSION: Avoiding severe breast symptoms rather than 2 year longer disease free survival is considered most important in our population of breast cancerpatients for evaluation of quality of care. These data should thus be included in both information provision prior to treatment choices and post treatment quality of care evaluation.
Authors: Karen R Sepucha; Aisha T Langford; Jeffrey K Belkora; Yuchiao Chang; Beverly Moy; Ann H Partridge; Clara N Lee Journal: Med Decis Making Date: 2019-07-29 Impact factor: 2.583
Authors: Elles M F van de Voort; Taco M A L Klem; Gerson M Struik; Erwin Birnie; Renata H J A Sinke; Ali Ghandi Journal: Br J Radiol Date: 2020-07-20 Impact factor: 3.039
Authors: Anna Janssen; Candice Donnelly; Judy Kay; Peter Thiem; Aldo Saavedra; Nirmala Pathmanathan; Elisabeth Elder; Phuong Dinh; Masrura Kabir; Kirsten Jackson; Paul Harnett; Tim Shaw Journal: J Med Internet Res Date: 2020-04-21 Impact factor: 5.428
Authors: Elena Tsangaris; Maria Edelen; Jessica Means; Madelijn Gregorowitsch; Joanna O'Gorman; Rakasa Pattanaik; Laura Dominici; Michael Hassett; Mary Lynch Witkowski; Kristen Schrieber; Elizabeth Frank; Martha Carnie; Andrea Pusic Journal: BMJ Surg Interv Health Technol Date: 2022-04-05
Authors: Kerry Ettridge; Joanna Caruso; David Roder; Ivanka Prichard; Katrine Scharling-Gamba; Kathleen Wright; Caroline Miller Journal: Qual Life Res Date: 2020-09-29 Impact factor: 3.440